ENANTA PHARMACEUTICALS INC (ENTA)

US29251M1062 - Common Stock

12.37  -0.11 (-0.88%)

After market: 12.37 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-12-31)
2023
(2023-9-30)
2022
(2022-9-30)
2021
(2021-9-30)
2020
(2020-9-30)
Revenue
73.62M79.20M86.20M97.10M122.50M
Operating Expenses
215.71M216.40M210.00M206.60M164.10M
Research and Development
159.00M163.50M164.50M174.10M136.80M
Selling, General, and Administrative Expenses
56.72M52.90M45.50M32.50M27.40M
Operating Income
-142.08M-137.20M-123.80M-109.60M-41.60M
Interest Income/Expense
6.08M6.20M1.70M2.00M6.60M
Income Before Taxes
-136.00M-131.00M-122.20M-107.60M-35.00M
Income Tax
2.23M2.80M-400.00K-28.60M1.10M
Net Income
-138.25M-133.80M-121.80M-79.00M-36.20M
EBITDA
-139.57M-134.83M-120.83M-106.27M-37.96M
 
Per Share Data
EPS Diluted Total Ops
-6.56-6.38-5.91-3.92-1.81
Non GAAP EPS
-6.56-6.37-5.91-3.91-1.82
 
Statistics
Profit Margin
-187.78%-168.94%-141.30%-81.36%-29.55%
Operating Profit Margin
-192.98%-173.23%-143.62%-112.87%-33.96%

All data in USD

Charts